My feet have widened and my toes are tender to bend, which has reduced my mobility somewhat
Wegovy: FDA-Approved Weight Loss Medication FDA Approval and Primary Use Wegovy is FDA-approved specifically for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) who have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol
This aligns closely with the approximately 15% average weight loss seen with injectable Wegovy in earlier phase 3 trials, although the studies were not head-to-head and involved different designs and populations
[DOI] [PubMed] [Google Scholar] 65.Carlin J.I., Harris R.C., Cederblad G., Constantin-Teodosiu D., Snow D.H., Hultman E
Tracking your response: building your personal data set The science on tirzepatide and migraines is still being written
Guaifenesin does not significantly affect how your stomach or intestines work, so it does not directly interfere with drug absorption for most medications